Blockade of Costimulation Between T Cells and Antigen-Presenting Cells: An Approach to Suppress Murine Graves' Disease Induced Using Thyrotropin Receptor-Expressing Adenovirus
- 1 May 2006
- journal article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 16 (5), 427-434
- https://doi.org/10.1089/thy.2006.16.427
Abstract
Immune responses require costimulatory interactions between molecules on antigen-presenting cells and T cells: CD40 binding to CD40 ligand and B7 binding to CD28. Graves' hyperthyroidism is induced in BALB/c mice by immunization with thyrotropin receptor (TSHR) A-subunit adenovirus (Ad-A-subunit). We attempted to modulate Ad-A-subunit-induced Graves' disease using adenoviruses expressing costimulation "decoys": CD40-IgG-Fc (CD40-Ig) to block CD40:CD40-ligand interactions and CTLA4-Fc (CTLA4-Ig) to prevent B7:CD28 binding. Unexpectedly, coimmunizing mice with Ad-A-subunit and excess control adenovirus (1:10 Ad-A-subunit:Ad-control) reduced TSHR antibody levels (thyrotropin binding inhibition [TBI]). Furthermore, only 15% of mice developed hyperthyroidism versus 75% using the same Ad-A-subunit dose (10(8) particles) without Ad-control. This effect was related to the dose of control adenovirus but not to the adenovirus insert, the timing or immunization site. Increasing the Ad-subunit dose (10(9) particles) and decreasing the control adenovirus dose (10:1 Ad-A-subunit:Ad-control) induced high TBI levels and 80% of mice were hyperthyroid. Coimmunization with Ad-CD40-Ig (but not Ad-CTLA4-Ig) reduced the incidence of hyperthyroidism to 40%. Using appropriate controls and adenovirus ratios, our data suggest the importance of CD40:CD40-ligand interactions for inducing Graves' hyperthyroidism by Ad-A-subunit. Furthermore, our observations emphasize the potential pitfalls of non-specific inhibition by coimmunization with two adenovirus species.Keywords
This publication has 29 references indexed in Scilit:
- Differential Requirement of Signal Transducer and Activator of Transcription-4 (Stat4) and Stat6 in a Thyrotropin Receptor-289-Adenovirus-Induced Model of Graves’ HyperthyroidismEndocrinology, 2006
- Insight into Graves’ Hyperthyroidism from Animal ModelsEndocrine Reviews, 2005
- Insight into antibody responses induced by plasmid or adenoviral vectors encoding thyroid peroxidase, a major thyroid autoantigenClinical and Experimental Immunology, 2003
- Targeted Delivery of Anti-CTLA-4 Antibody Downregulates T Cell Function in Vitro and in VivoClinical Immunology, 2001
- Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cellsGene Therapy, 2000
- CTLA4Ig inhibits T cell–dependent B-cell maturation in murine systemic lupus erythematosusJCI Insight, 2000
- Persistent and Secondary Adenovirus-Mediated Hepatic Gene Expression Using Adenovirus Vector Containing CTLA4IgGHuman Gene Therapy, 1998
- Suppression of murine thyroiditis via blockade of the CD40–CD40L interactionImmunology, 1997
- A central role of CD40 ligand in the regulation of CD4+ T-cell responsesImmunology Today, 1996
- New perspectives of C1328-137-mediated T cell costimulationImmunity, 1995